| LncRNA FOXD3-AS1 Contributes to Glioblastoma Progression Via Sponging miR-3918 to Upregulate CCND1. | LncRNA FOXD3-AS1 Contributes to Glioblastoma Progression Via Sponging miR-3918 to Upregulate CCND1.
Huang C, Shao T, Duan F, Li R, Luo M, Huang Q, Wang Y, Luo Z. | 03/22/2024 |
| Reduction of GAS5 and FOXD3-AS1 long non-coding RNAs in patients with bipolar disorder. | Reduction of GAS5 and FOXD3-AS1 long non-coding RNAs in patients with bipolar disorder.
Zamani B, Mehrab Mohseni M, Naghavi Gargari B, Taheri M, Sayad A, Shirvani-Farsani Z., Free PMC Article | 09/1/2023 |
| Mechanism of lncRNA FOXD3-AS1/miR-338-3p in the malignant progression of nasopharyngeal carcinoma through ceRNA. | Mechanism of lncRNA FOXD3-AS1/miR-338-3p in the malignant progression of nasopharyngeal carcinoma through ceRNA.
Li Y, Zhao S, Chen B. | 08/25/2023 |
| LncRNA FOXD3-AS1/miR-128-3p axis-mediated IGF2BP3 in glioma stimulates cancer angiogenesis and progression. | LncRNA FOXD3-AS1/miR-128-3p axis-mediated IGF2BP3 in glioma stimulates cancer angiogenesis and progression.
Zhao H, Wang Y, Liang C, Xie M. | 08/19/2023 |
| LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6. | LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Zhang X, Zhao X, Chang L, Liu F, Li C, Ge P. | 08/27/2022 |
| Oncogenic Forkhead box D3 antisense RNA 1 promotes cell survival and confers temozolomide resistance in glioblastoma cells through the miR-128-3p/WEE1 G2 checkpoint kinase axis. | Oncogenic Forkhead box D3 antisense RNA 1 promotes cell survival and confers temozolomide resistance in glioblastoma cells through the miR-128-3p/WEE1 G2 checkpoint kinase axis.
Ling Z, Zhang J, Liu Q., Free PMC Article | 04/23/2022 |
| Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance. | Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.
Mao G, Mu Z, Wu DA. | 02/19/2022 |
| Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation. | Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation.
Hu J, Pan J, Luo Z, Duan Q, Wang D. | 02/12/2022 |
| Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis. | Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis.
Ren L, Zhou H, Lei L, Zhang Y, Cai H, Wang X., Free PMC Article | 12/25/2021 |
| FOXD3AS1/miR1283p/LIMK1 axis regulates cervical cancer progression. | FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression.
Yang X, Du H, Bian W, Li Q, Sun H., Free PMC Article | 11/6/2021 |
| FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis. | FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
Ji T, Zhang Y, Wang Z, Hou Z, Gao X, Zhang X. | 07/17/2021 |
| FOXD3-AS1 Contributes to the Progression of Melanoma Via miR-127-3p/FJX1 Axis. | FOXD3-AS1 Contributes to the Progression of Melanoma Via miR-127-3p/FJX1 Axis.
Wan N, Yang W, Cheng H, Wang J. | 07/3/2021 |
| Long non-coding RNA FOXD3-AS1 regulates the expression and secretion of IL-25 in nasal epithelial cells to inhibit Th2 type immunoreaction in allergic rhinitis. | Long non-coding RNA FOXD3-AS1 regulates the expression and secretion of IL-25 in nasal epithelial cells to inhibit Th2 type immunoreaction in allergic rhinitis.
Zhang H, Zhu X, Liu X, Wang Y, Liu Y. | 05/1/2021 |
| Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-beta1/Smads signaling pathway. | Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y, Gao H, Li Y. | 11/21/2020 |
| FOXD3-AS1 promotes colorectal cancer (CRC) progression by regulating miR-135a-5p/SIRT1 axis, shedding lights on the way to CRC treatments | Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
Wu Q, Shi M, Meng W, Wang Y, Hui P, Ma J. | 06/13/2020 |
| LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma by regulating miR-325/MAP3K2 axis. | LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X, Gao J, Yu Y, Zhao Z, Pan Y. | 04/25/2020 |
| lncRNA FOXD3-AS1 has significantly high expression in breast cancer cell lines comparing with the normal tissue; besides, findings suggested that lncRNA FOXD3-AS1 could play a potential diagnostics or prognostic biomarker for patients with breast cancer | lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer.
Guan Y, Bhandari A, Xia E, Yang F, Xiang J, Wang O. | 08/17/2019 |